Lakefront Biotherapeutic...【GXE】銘柄情報

Lakefront Biotherapeutics NV (GXE) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

26.72

( -0.37% )

買値

26.62

売値

26.80

出来高

平均取引量 (3 か月)

72,853 €

財務取引量

26.56 日の範囲 26.84

22.78 52 週間の範囲 32.64

時価総額

1.761B

企業価値

-1.203B

前日終値

26.82

始値

26.84

時刻

26.56

最終取引時間

VWAP

歳入

1.04B

純利益

488.78M

発行済株式数

65,897,071

浮動株比率 (%)

62.13%

機関投資家保有比率 (%)

42.28%

配当利回り

PER

3.63

株価売上高倍率 (PSR)

1.7

1 株当たり利益 (EPS)

7.42

ベータ

0.12

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG51... Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

lakefrontbio.com

本社

Mechelen, Belgium

設立

1999

Lakefront Biotherapeutics NV is listed in the Healthcare sector of the Tradegate (DE) with ticker GXE. The last closing price for Lakefront Biotherapeutic... was 26.82 €. Over the last year, Lakefront Biotherapeutic... shares have traded in a share price range of 22.78 € to 32.64 €.

Lakefront Biotherapeutic... currently has 65,897,071 shares in issue. The market capitalisation of Lakefront Biotherapeutic... is 1.76 € billion. Lakefront Biotherapeutic... has a price to earnings ratio (PE ratio) of 3.63.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.84	3.2457496136	25.88	26.9	25.88	377	26.6140146	DE
4	2.04	8.26580226904	24.68	26.9	24.42	468	25.53270516	DE
12	2.14	8.70626525631	24.58	26.9	22.78	603	24.22509679	DE
26	-1.58	-5.58303886926	28.3	30.5	22.78	665	26.35243257	DE
52	1.72	6.88	25	32.64	22.78	1225	27.61310973	DE
156	-8.03	-23.1079136691	34.75	38.9	20.2	3912	26.70133093	DE
260	-31.37	-54.0024100534	58.09	66.4	20.2	2801	27.51422009	DE